
Northland Securities Keeps Their Buy Rating on Spectral AI (MDAI)

Northland Securities has maintained a Buy rating on Spectral AI (MDAI) with a price target of $6.00, as reported by Carl Byrnes. Additionally, BTIG also holds a Buy rating for the stock, setting a price target of $3.00. Byrnes focuses on the Healthcare sector and has an average return of -4.1% with a 36.78% success rate on his stock recommendations.
In a report released today, Carl Byrnes from Northland Securities maintained a Buy rating on Spectral AI, with a price target of $6.00.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Byrnes covers the Healthcare sector, focusing on stocks such as Brainsway, Alvotech, and BioLife Solutions. According to TipRanks, Byrnes has an average return of -4.1% and a 36.78% success rate on recommended stocks.
In a report released today, BTIG also maintained a Buy rating on the stock with a $3.00 price target.

